TAAR1 and bipolar disorder: Current evidence strongly suggests that TAAR1 agonists could represent potential pharmacotherapy options for managing stress-related disorders, including depression, bipolar disorder, and anxiety disorders such as PTSD, offering hope for more effective and safer treatments in the realm of mental health.